BioCentury
ARTICLE | Clinical News

Novastan thrombin inhibitor: Began Phase II trial in 120 patients

October 16, 1995 7:00 AM UTC

Texas Biotechnology Corp. (TXB), Houston Product: Novastan thrombin inhibitor Indication: Adjunct to tPA and aspirin in acute myocardial infarction Status: Began Phase II trial in 120 patients ...